Clinical Trials Logo

Clinical Trial Summary

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the objective of territorial coverage by regional expert centers and systematic discussion of patients management at national tumor board.


Clinical Trial Description

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in 2012 by the French National Cancer Institute. The objectives of the network are management of clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is based on initial histopathological diagnosis. RYTHMIC is a comprehensive tool for research: - to improve the management of patients - to monitor dedicated actions - to screen patients for future translational and clinical trials ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02724696
Study type Observational
Source Intergroupe Francophone de Cancerologie Thoracique
Contact Franck Morin
Email contact@ifct.fr
Status Recruiting
Phase
Start date January 2012
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05446935 - Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence N/A
Not yet recruiting NCT06200233 - Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor Phase 2
Not yet recruiting NCT03212027 - Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging N/A
Recruiting NCT04667793 - Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor Phase 2
Recruiting NCT05667948 - Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting NCT04522687 - Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Recruiting NCT04417660 - Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma Phase 2
Not yet recruiting NCT04517539 - Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors Phase 2
Recruiting NCT06301945 - Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Recruiting NCT05104736 - PT-112 in Subjects With Thymoma and Thymic Carcinoma Phase 2
Recruiting NCT03858582 - neoadjuvant_thymic Epithelial Tumor Phase 2
Recruiting NCT06311955 - Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor Phase 2